生物阻抗谱估计维持性血液透析患者的目标体重。

IF 8.8 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cochrane Database of Systematic Reviews Pub Date : 2025-09-18 DOI:10.1002/14651858.CD016044

Kaiane Stigger, Eduardo Ribes Kohn, Rony Kafer Nobre, Guilherme Pitol, Natan Feter, Maristela Bohlke

引用次数: 0

摘要

目的：这是Cochrane综述（干预）的一个方案。目的如下：与单纯体检相比，评价将生物阻抗谱纳入维持性血液透析受者目标体重的临床评估的利与弊。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Bioimpedance spectroscopy to estimate target weight in patients on maintenance haemodialysis.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of incorporating bioimpedance spectroscopy into the clinical assessment for estimating target weight in maintenance haemodialysis recipients compared with physical examination alone.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cochrane Database of Systematic Reviews 医学-医学：内科

CiteScore

10.60

自引率

2.40%

发文量

173

审稿时长

1-2 weeks

期刊介绍： The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.